Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2B Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)

NCT00252239 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT00252239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00252239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2B Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)
Lead sponsor
University of Virginia
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2005
Completion date
September 30, 2009
Enrollment
112 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

stroke